REG - Surgical Innovations - Directorate Change <Origin Href="QuoteRef">SUNU.L</Origin>

Surgical InnovationsAnnouncement

28/10/2015 07:02

RNS Number : 6262D
Surgical Innovations Group PLC
28 October 2015
Surgical Innovations Group plc
(the "Company" or "SI")
Directorate Change
The Company announces the appointment of Nigel Rogers as Executive Chairman with immediate effect. Doug Liversidge CBE, previously Non-Executive Chairman, has stood down as Chairman, but remains on the Board as a Non-Executive Director.
Nigel qualified as a Chartered Accountant in 1983 spending eight years with PwC before moving into industry. He managed the flotation of Stadium Group plc ("Stadium") as Group Finance Director, before progressing to Group Chief Executive Officer in 2001. Under his leadership, Stadium divested several non-core businesses, focusing on the successful development of its electronic design and manufacturing capabilities in the UK and China to a global customer base. He joined 600 Group plc as Group Chief Executive Officer in 2012 and led the turnaround of the AIM-quoted global machine tool business (Colchester-Harrison), increasing strategic focus on the growth of its laser marking business (Electrox) until April 2015. Nigel has been Non-Executive Deputy Chairman of Transense Technologies plc, the AIM-quoted provider of sensor systems, since July 2015.
Doug Liversidge commented: "The role of chairman of SI has become more demanding in time over recent months and I welcome wholeheartedly the introduction of Nigel to the Board as Executive Chairman. I have no doubt that he will drive the Company forward drawing on his extensive experience."
Nigel Rogers commented: "Following a difficult period, SI has been successfully stabilised through the hard work and commitment of the Board and major shareholders. I am looking forward to supporting the Board and executive management team in moving the business forward for the benefit of all stakeholders.
"I would also like to place on record the Board's appreciation for Doug's leadership of the board of SI over many years."
Further information on Nigel Rogers
The following information is disclosed pursuant to Schedule Two paragraph (g) of the AIM Rules for Companies. Nigel Foster Rogers, aged 54, is currently a director of the following companies:
Can Vives Limited
Transense Technologies plc
Mr. Rogers has also been a director or partner of the following company or partnership in the five years preceding this announcement:
600 Group plc
600 Group Inc.
600 (Machine Tools) Pty.
600 SPV1 Limited
600 SPV2 Limited
600 UK Limited
Ariel Pressings Limited
Ferrus Power Limited
Fox Industries Limited
Hale End Holdings Limited
Ingram Electronic Services Limited
Kingslo Limited
KRP Power Source (UK) Limited
Stadium Electrical Holdings Limited
Stadium Electronics Limited
Stadium Group plc
Stadium Power Limited
Stadium Wireless Devices plc
Stadium Zirkon UK Limited
TYKMA Inc.
Valuegolden Limited
Zirkon Holdings Limited
Mr. Rogers does not hold any ordinary shares in the Company. However, a proportion of his remuneration will be satisfied through the issue of ordinary shares in the Company. It is intended that, subject to any regulatory restrictions, ordinary shares will be issued to him on a quarterly basis. Announcements will be made at that time.
ENDS
For further information please visit www.sigroupplc.com or contact:
Enquiries:
Surgical Innovations Group plc 
Nigel Rogers
Executive Chairman
Tel: 07767 603362
WH Ireland Limited (Nominated Adviser and Broker)
Tim Feather / Liam Gribben
Tel: 0113 394 6600

This information is provided by RNS
The company news service from the London Stock Exchange
  END
BOAPGGRAUUPAGQM